Colleen Corey - Apr 26, 2023 Form 3 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Global Human Resources
Signature
/s/ Colleen Corey
Stock symbol
BIO
Transactions as of
Apr 26, 2023
Transactions value $
$0
Form type
3
Date filed
5/4/2023, 05:06 PM
Next filing
Sep 6, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO Bio-Rad A Common Stock 15.9K Apr 26, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIO Restricted Stock Units Apr 26, 2023 Bio-Rad A Common Stock 600 $0.00 Direct F1, F6
holding BIO Restricted Stock Units Apr 26, 2023 Bio-Rad A Common Stock 990 $0.00 Direct F2, F6
holding BIO Restricted Stock Units Apr 26, 2023 Bio-Rad A Common Stock 722 $0.00 Direct F3, F6
holding BIO Restricted Stock Units Apr 26, 2023 Bio-Rad A Common Stock 760 $0.00 Direct F4, F6
holding BIO Restricted Stock Units Apr 26, 2023 Bio-Rad A Common Stock 1.39K $0.00 Direct F5, F6
holding BIO Non-Qualified Stock Option (right to buy) Apr 26, 2023 Bio-Rad A Common Stock 1.44K $524.30 Direct F7
holding BIO Non-Qualified Stock Option (right to buy) Apr 26, 2023 Bio-Rad A Common Stock 1.01K $814.95 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F2 On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F3 On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4 On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5 On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F7 The option, representing a right to purchase a total of 1,444 shares, becomes exercisable in four equal annual installments beginning on September 2, 2021, which is the first anniversary of the date on which the option was granted.
F8 The option, representing a right to purchase a total of 1,013 shares, becomes exercisable in four equal annual installments beginning on September 1, 2022, which is the first anniversary of the date on which the option was granted.